{
    "Trade/Device Name(s)": [
        "VITEK 2 Gram Negative Ceftriaxone",
        "VITEK 2 AST-GN Ceftriaxone"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K161217",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121546"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "December 22, 2016",
    "Summary Letter Received Date": "December 23, 2016",
    "Submission Date": "December 2, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftriaxone susceptibility in Gram-negative bacilli",
        "Enterobacter aerogenes",
        "Escherichia coli",
        "Klebsiella oxytoca",
        "Klebsiella pneumoniae",
        "Proteus mirabilis",
        "Serratia marcescens",
        "Citrobacter koseri",
        "Citrobacter freundii",
        "Shigella species",
        "Providencia species",
        "Salmonella species"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of aerobic gram-negative bacilli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2 System",
        "VITEK 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Antimicrobial susceptibility testing (AST)",
        "Minimum inhibitory concentration (MIC) determination",
        "Microdilution"
    ],
    "Methodologies": [
        "Automated quantitative or qualitative susceptibility testing",
        "Doubling dilution technique",
        "Microdilution methodology"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 Gram Negative Ceftriaxone assay for automated susceptibility testing of Gram-negative bacilli using VITEK 2 instrument platforms",
    "Indications for Use Summary": "Intended for antimicrobial susceptibility testing of Gram-negative bacilli as a laboratory aid to determine in vitro susceptibility to ceftriaxone using VITEK 2 systems",
    "fda_folder": "Microbiology"
}